Raymond James Financial Services Advisors, Inc. Jupiter Wellness, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	N/A	15,019 New	15,019 $43,000
Q2 2023 Jul 25, 2023	SELL	$0.32 - $0.52 $1,148 - $1,866	-3,589 Reduced 26.12%	10,150 $4,000
Q4 2022 Feb 08, 2023	BUY	$0.76 - $1.44 $10,441 - $19,784	13,739 New	13,739 $10,000

Others Institutions Holding JUPW

# of Institutions

Shares Held

5.15M

Call Options Held

10.1K

Put Options Held

11.8K

Glenview Trust CO Louisville, KY

2M
Shares

$5.84 Million
0.12% of portfolio
Black Rock Inc. New York, NY

678K
Shares

$1.98 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

459K
Shares

$1.34 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

396K
Shares

$1.16 Million
0.0% of portfolio
M Holdings Securities, Inc. Portland, OR

152K
Shares

$445,191
0.02% of portfolio

View Full List

About Jupiter Wellness, Inc.

Ticker JUPW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 22,095,000
Market Cap $64.5M
Description
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and J...

More about JUPW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account